INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...

The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company ...

The Humalog Junior KwikPen, a prefilled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 or type 2 diabetes, is now available for prescription in the U.S., Eli ...

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...

Eli Lilly and Company announced that the US Food and Drug Administration (FDA) approved the company's supplemental New Drug Application (sNDA) with the following updates to the Humalog label: ...

Humalog Junior KwikPen U-100 will be available as 5-count cartons. The BD pen needles are recommended for use with Humalog Junior KwiKPen. The Humalog Junior KwikPen (insulin lispro; Eli Lilly), a ...

The InPen is for use with U-100 Lilly Humalog and Novo Nordisk Novolog rapid-acting insulin and indicated for persons aged 12 years and older. Companion Medical announced the launch of the InPen ...

The same dose with half the liquid volume. That's the claim of a new insulin pen from Eli Lilly and Co. The Indianapolis drugmaker became the first company to get federal approval to sell pre-filled ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated ...

A cheaper generic version of the rapid-acting insulin Humalog has hit the market, according to a statement Wednesday by drugmaker Eli Lilly. The company announced its plans in March amid growing ...